The pharmaceutical company Bristol Myers Squibb (BMS) is now enrolling for two clinical trials in liver cancer (also called hepatocellular carcinoma or HCC). These trials have the reference numbers CA209-9DW and CA209-74W. If you are eligible and willing and able to take part, you will be helping to advance research. Eligible participants must be at least age 18 years old and diagnosed with liver cancer. These two trials are researching the safety and efficacy of new study drugs compared to a standard of care (CA209-74W) and to other standard drugs (CA209-9DW). Click here to learn more about full trial requirements, lists of tests and procedures used to determine trial eligibility, and more details about clinical trial participation in general.